Klaus Kallenbach
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Response to "Weight-loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk".
Journal: Obesity (Silver Spring, Md.)
Published: May 19, 2025
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.
Journal: Obesity (Silver Spring, Md.)
Published: August 13, 2024
Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.
Journal: Diabetes, obesity & metabolism
Published: December 16, 2021
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 22, 2020
Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States.
Journal: Advances in therapy
Published: September 24, 2019
Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome.
Journal: Health science reports
Published: February 14, 2018
Haematoxylin and eosin staining identifies medium to large bacterial aggregates with a reliable specificity: A comparative analysis of follicular bacterial aggregates in axillary biopsies using peptide nucleic acid-fluorescence in situ hybridization and haematoxylin and eosin staining.
Journal: Experimental dermatology
Published: February 23, 2017
Bacterial biofilm in chronic lesions of hidradenitis suppurativa.
Journal: The British journal of dermatology
Published: August 21, 2016
Last Updated: 09/26/2026